Company / Current Liabilities per Share
Kura Oncology, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.50
FY2025
5-year range
$0.34 / $1.50
FY2021-FY2025
Trend
+41.2%
vs FY2024
Sector context
#89 of 210
Health Care
What the data says
At $1.50, Kura Oncology, Inc.'s current liabilities per share ranks #122 of 210 in the Health Care sector. Current Liabilities per Share has increased for 4 consecutive years, from $0.34 in FY2021 to $1.50 in FY2025.
Based on SEC 10-K filings.
1.50 in FY2025 with a 5-year CAGR of +25.0%.
Increased from $0.48 to $1.50 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +60.9%
- 5-Year CAGR
- +25.0%
- 10-Year CAGR
- -
Sector benchmark
#122 of 210 in Health CareTop 58% of 210This company $1.50 Sector average $23.79
▼
-93.7% below sector average
Key checks
Key Insights
- Kura Oncology, Inc.'s current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 41.2% year-over-year.
- Ranks #89 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.50 | +41.2% |
| FY2024 | $1.06 | +119.8% |
| FY2023 | $0.48 | +34.1% |
| FY2022 | $0.36 | +6.1% |
| FY2021 | $0.34 | -31.0% |
| FY2020 | $0.49 | +32.1% |
| FY2019 | $0.37 | -4.1% |
| FY2018 | $0.39 | -10.4% |
| FY2017 | $0.43 | +48.1% |
| FY2016 | $0.29 | -42.7% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026